Daily Outlook - Sept 28
Xerox Shifts to Outsourcing; J&J's Biotech Bet; Abbott Expands
Xerox to buy Affiliated Computer for $6.4 billion
Xerox Corp said on Monday it will buy Affiliated Computer Services Inc for $6.4 billion in a cash and stock deal that expands the copier company into technology outsourcing and data management. Read Full Article.
Johnson & Johnson buys 18 percent stake in Crucell
U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday. Read Full Article.
Solvay sells drugs unit to Abbott for $6.6 billion
Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics. Read Full Article.
Unicom to sell Apple iPhones in China from October
China Unicom, the country's No. 2 mobile carrier, will begin to sell Apple Inc's iPhone in China for a retail price of 5,000 yuan ($732.50), as it leans on the phone to launch its 3G service. Read Full Article.
Australia court allows claims against Lehman
An Australian court has ruled that local governments can pursue financial claims against collapsed U.S. investment bank Lehman Brothers in Australia and elsewhere, a firm that is funding the litigation said on Monday. Read Full Article.
BofA suspends ACORN commitments: report
Bank of America Corp has suspended its current commitments to ACORN Housing, an affiliate of Association of Community Organizations for Reform Now (ACORN), a scandal-hit U.S. liberal grassroots group, the Wall Street Journal said on Monday. Read Full Article.
Merkel wins as Germans choose centre-right
German voters gave Chancellor Angela Merkel a second term on Sunday and a mandate to partner with the pro-business Free Democrats (FDP) in a government that will rein in the role of the state in Europe's largest economy. Read Full Article.
© Copyright IBTimes 2024. All rights reserved.